US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aspire Biopharma Holdings Inc.

7.89

-0.0800-1.00%

Volume:39.26K

Turnover:315.37K

Market Cap:11.07M

PE:-0.92

High:8.17

Open:7.90

Low:7.89

Close:7.97

52wk High:714.00

52wk Low:3.31

Shares:1.40M

Float Shares:1.11M

Volume Ratio:2.46

T/O Rate:3.53%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-8.5310

EPS(LYR):-491.2689

ROE:-1032.14%

ROA:60.58%

PB:0.94

PE(LYR):-0.02

Loading ...

Overview Company News Filings

Aspire Biopharma Q2 FY26 Net Loss Narrows to $1.27 Million; Revenue Rises to $63,104

Aspire Biopharma to Present at Sidoti Micro-Cap Virtual Investor Conference

Aspire Biopharma Completes $30 Million Acquisition of Dura Driver Control Systems

Aspire Biopharma Holdings Inc trading resumes

NASDAQ Trade Halt Volatility Trading Pause at 12:20 Pm

Aspire Biopharma Says ASPBW Warrants Now Carry Exercise Price of 13,800 Per Share After Reverse Splits

Aspire Biopharma appoints Jarryd McNeil as sponsored athlete for BUZZ BOMB

Aspire Biopharma Posts June 2026 Investor Presentation for On-demand Viewing

Aspire Unit Buzz Bomb Caffeine Launches BUZZ BOMB 50 Mg Caffeine Stick Packs on Amazon

Aspire Biopharma posts investor deck on sublingual drug-delivery platform, lead sublingual aspirin program

Aspire Biopharma to present at Life Sciences Virtual Investor Forum

Aspire Biopharma stockholders approve warrant share issuance proposal at special meeting

Aspire Biopharma to present at Life Sciences Investor Forum hosted by VirtualInvestorConferences.com

Aspire Biopharma delays shareholder meeting to June 16 after lacking quorum

Aspire Biopharma Holdings Inc trading halted, volatility trading pause

Top Midday Decliners

MT Newswires Live

Press Release: Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue

Aspire Biopharma - Enters Purchase Agreement With Firefish Topco on June 10, 2026 - SEC Filing

THOMSON REUTERS

Aspire Biopharma - to Pay $30 Mln Plus $800,000 Deferred Revenue as Purchase Price - SEC Filing

THOMSON REUTERS

Aspire Biopharma signs agreement to buy Dura Driver Control Systems for $30 million cash

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/ASBP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ASBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASBP\",,,,,undefined,":{"symbol":"ASBP","market":"US","secType":"STK","nameCN":"Aspire Biopharma Holdings Inc.","latestPrice":7.89,"timestamp":1787592705956,"preClose":7.97,"halted":0,"volume":39263,"delay":0,"changeRate":-0.010037641154328742,"floatShares":1113605,"shares":1402600,"eps":-8.531,"marketStatus":"Trading","change":-0.08,"latestTime":"08-24 13:36:01 EDT","open":7.9,"high":8.17,"low":7.89,"amount":315365.79503100005,"amplitude":0.035132,"askPrice":7.94,"askSize":49,"bidPrice":7.64,"bidSize":9,"shortable":3,"etf":0,"ttmEps":-8.531,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":7.97,"preHourTrading":{"tag":"盘前","latestPrice":7.5318,"preClose":7.97,"latestTime":"09:25 EDT","volume":3385,"amount":25426.005729,"timestamp":1787577933519,"change":-0.4382,"changeRate":-0.054981,"amplitude":0.048934},"postHourTrading":{"tag":"盘后","latestPrice":8.16,"preClose":7.97,"latestTime":"19:49 EDT","volume":4660,"amount":37511.6259,"timestamp":1787356199785,"change":0.19,"changeRate":0.023839,"amplitude":0.023839},"volumeRatio":2.456131},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASBP\",,,,,undefined,":{"symbol":"ASBP","floatShares":1113605,"roa":"60.58%","roe":"-1032.14%","lyrEps":-491.26893,"volumeRatio":2.456131,"shares":1402600,"dividePrice":0,"high":8.17,"amplitude":0.035132,"preClose":7.97,"low":7.89,"week52Low":3.309,"pbRate":"0.94","psRate":"113.32","week52High":714,"institutionHeld":0,"latestPrice":7.89,"committee":-0.689655,"eps":-8.531,"divideRate":0,"volume":39263,"delay":0,"ttmEps":-8.531,"open":7.9,"prevYearClose":158.28,"prevWeekClose":7.97,"prevMonthClose":6.52,"prevQuarterClose":5.34,"fiveDayClose":7.74,"twentyDayClose":6.97,"sixtyDayClose":5.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ASBP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-11","symbol":"ASBP","defaultRemindTime":1778506200000,"type":"split","dateTimestamp":1778472000000,"forFactor":30,"toFactor":1,"ratio":30},{"market":"US","date":"2026-01-16","symbol":"ASBP","defaultRemindTime":1768573800000,"type":"split","dateTimestamp":1768539600000,"forFactor":40,"toFactor":1,"ratio":40}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ASBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ASBP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ASBP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ASBP","date":"2026-08-21","current":-0.924862,"percent":0.330623,"low":-107.647863,"twenty":-1.256688,"median":-0.732274,"eighty":-0.235513,"high":-0.03181,"avg":-6.481179,"sd":15.293099,"marketCap":10967995},"quantilePoints":[{"date":"2025-03-07","current":-61.718107,"twenty":-79.515888,"median":-61.718107,"eighty":-58.474317,"marketCap":40003023},{"date":"2025-03-14","current":-41.62384,"twenty":-63.871064,"median":-57.344015,"eighty":-54.828644,"marketCap":26978783},{"date":"2025-03-21","current":-49.388839,"twenty":-61.718107,"median":-55.259235,"eighty":-45.464716,"marketCap":32011722},{"date":"2025-03-28","current":-47.36506,"twenty":-59.766092,"median":-48.376949,"eighty":-45.613987,"marketCap":30699995},{"date":"2025-04-04","current":-38.75323,"twenty":-56.183571,"median":-46.367595,"eighty":-43.647619,"marketCap":25118177},{"date":"2025-04-11","current":-38.035578,"twenty":-55.34679,"median":-45.929755,"eighty":-40.946376,"marketCap":24653026},{"date":"2025-04-17","current":-39.57853,"twenty":-55.287942,"median":-45.474044,"eighty":-39.546954,"marketCap":25653101},{"date":"2025-04-25","current":-36.428037,"twenty":-53.967461,"median":-44.487272,"eighty":-38.006872,"marketCap":23611087},{"date":"2025-05-02","current":-25.763721,"twenty":-50.875815,"median":-42.879731,"eighty":-36.06634,"marketCap":16698936},{"date":"2025-05-09","current":-24.070062,"twenty":-48.174572,"median":-41.62384,"eighty":-32.456117,"marketCap":15601179},{"date":"2025-05-16","current":-8.64997,"twenty":-47.360753,"median":-40.170558,"eighty":-27.896584,"marketCap":11330354},{"date":"2025-05-23","current":-0.643502,"twenty":-46.76371,"median":-38.75323,"eighty":-25.110657,"marketCap":10952545},{"date":"2025-05-30","current":-1.730761,"twenty":-46.192459,"median":-37.963813,"eighty":-23.557658,"marketCap":29457944},{"date":"2025-06-06","current":-0.976857,"twenty":-45.929755,"median":-36.514155,"eighty":-4.677726,"marketCap":16626329},{"date":"2025-06-13","current":-1.091781,"twenty":-45.929755,"median":-34.956848,"eighty":-1.13913,"marketCap":18582368},{"date":"2025-06-20","current":-0.913361,"twenty":-45.88526,"median":-32.509654,"eighty":-1.103849,"marketCap":15545618},{"date":"2025-06-27","current":-0.879171,"twenty":-45.613987,"median":-30.966702,"eighty":-1.056614,"marketCap":14963696},{"date":"2025-07-03","current":-0.838948,"twenty":-45.240807,"median":-27.672677,"eighty":-0.926003,"marketCap":14279083},{"date":"2025-07-11","current":-0.994957,"twenty":-44.49445,"median":-25.763721,"eighty":-0.89957,"marketCap":16934405},{"date":"2025-07-18","current":-1.022827,"twenty":-44.487272,"median":-24.235121,"eighty":-0.913361,"marketCap":17408745},{"date":"2025-07-25","current":-1.492005,"twenty":-43.705031,"median":-23.47441,"eighty":-0.913361,"marketCap":25394273},{"date":"2025-08-01","current":-1.094942,"twenty":-43.417971,"median":-12.855253,"eighty":-0.926003,"marketCap":18636159},{"date":"2025-08-08","current":-0.957894,"twenty":-42.341491,"median":-1.730761,"eighty":-0.926003,"marketCap":16303583},{"date":"2025-08-15","current":-1.119076,"twenty":-41.810429,"median":-1.408829,"eighty":-0.936633,"marketCap":19046927},{"date":"2025-08-22","current":-1.407348,"twenty":-41.62384,"median":-1.381965,"eighty":-0.948126,"marketCap":26605351},{"date":"2025-08-29","current":-1.458172,"twenty":-41.494663,"median":-1.401585,"eighty":-0.950712,"marketCap":27566154},{"date":"2025-09-05","current":-1.427258,"twenty":-40.909001,"median":-1.428961,"eighty":-0.956458,"marketCap":26981748},{"date":"2025-09-12","current":-1.182832,"twenty":-39.815341,"median":-1.395821,"eighty":-0.96387,"marketCap":22360975},{"date":"2025-09-19","current":-1.153491,"twenty":-39.515377,"median":-1.375367,"eighty":-0.974558,"marketCap":21806284},{"date":"2025-09-26","current":-0.990278,"twenty":-38.902502,"median":-1.341067,"eighty":-0.987594,"marketCap":18720816},{"date":"2025-10-03","current":-1.100309,"twenty":-38.179108,"median":-1.232741,"eighty":-0.956458,"marketCap":20800907},{"date":"2025-10-10","current":-0.881819,"twenty":-37.978166,"median":-1.192915,"eighty":-0.950195,"marketCap":16670441},{"date":"2025-10-17","current":-0.836759,"twenty":-37.504515,"median":-1.176427,"eighty":-0.934507,"marketCap":15818594},{"date":"2025-10-24","current":-0.880247,"twenty":-36.758157,"median":-1.164494,"eighty":-0.913361,"marketCap":16640725},{"date":"2025-10-31","current":-0.986087,"twenty":-36.462484,"median":-1.14993,"eighty":-0.912711,"marketCap":18641575},{"date":"2025-11-07","current":-0.694243,"twenty":-35.704643,"median":-1.134878,"eighty":-0.909799,"marketCap":13124382},{"date":"2025-11-14","current":-0.275601,"twenty":-35.070237,"median":-1.124309,"eighty":-0.898954,"marketCap":5210132},{"date":"2025-11-21","current":-0.235902,"twenty":-33.9751,"median":-1.119076,"eighty":-0.881505,"marketCap":4838687},{"date":"2025-11-28","current":-0.553115,"twenty":-32.997658,"median":-1.106147,"eighty":-0.854611,"marketCap":11360337},{"date":"2025-12-05","current":-0.481425,"twenty":-32.429349,"median":-1.100309,"eighty":-0.832214,"marketCap":9887900},{"date":"2025-12-12","current":-0.546836,"twenty":-31.853289,"median":-1.093218,"eighty":-0.820326,"marketCap":11231365},{"date":"2025-12-19","current":-0.524858,"twenty":-30.859054,"median":-1.081231,"eighty":-0.778555,"marketCap":10779960},{"date":"2025-12-26","current":-0.507589,"twenty":-29.773963,"median":-1.072669,"eighty":-0.702707,"marketCap":10425286},{"date":"2026-01-02","current":-0.690217,"twenty":-28.344399,"median":-1.050409,"eighty":-0.690255,"marketCap":14176239},{"date":"2026-01-09","current":-0.540556,"twenty":-26.497162,"median":-1.035468,"eighty":-0.662273,"marketCap":11102392},{"date":"2026-01-16","current":-0.271586,"twenty":-26.171348,"median":-1.031821,"eighty":-0.631908,"marketCap":5578064},{"date":"2026-01-23","current":-0.236788,"twenty":-25.763721,"median":-1.0257,"eighty":-0.565151,"marketCap":4863341},{"date":"2026-01-30","current":-0.191,"twenty":-25.584308,"median":-1.01392,"eighty":-0.553115,"marketCap":3922916},{"date":"2026-02-06","current":-0.172685,"twenty":-24.400181,"median":-1.00377,"eighty":-0.544219,"marketCap":3546746},{"date":"2026-02-13","current":-0.171377,"twenty":-24.070062,"median":-0.994957,"eighty":-0.524858,"marketCap":3519876},{"date":"2026-02-20","current":-0.359587,"twenty":-23.760036,"median":-0.986087,"eighty":-0.515752,"marketCap":7385488},{"date":"2026-02-27","current":-0.354694,"twenty":-23.516034,"median":-0.961629,"eighty":-0.507589,"marketCap":7285005},{"date":"2026-03-06","current":-0.320448,"twenty":-23.365326,"median":-0.950712,"eighty":-0.493983,"marketCap":6581626},{"date":"2026-03-13","current":-0.275194,"twenty":-18.316039,"median":-0.944432,"eighty":-0.472111,"marketCap":5652159},{"date":"2026-03-20","current":-0.160836,"twenty":-10.332083,"median":-0.936633,"eighty":-0.400965,"marketCap":3303373},{"date":"2026-03-27","current":-0.222601,"twenty":-3.353645,"median":-0.92313,"eighty":-0.358608,"marketCap":4571969},{"date":"2026-04-02","current":-0.20728,"twenty":-1.850282,"median":-0.913361,"eighty":-0.349802,"marketCap":5074383},{"date":"2026-04-10","current":-0.246272,"twenty":-1.619708,"median":-0.910113,"eighty":-0.3317,"marketCap":6028948},{"date":"2026-04-17","current":-0.061568,"twenty":-1.539071,"median":-0.901599,"eighty":-0.30661,"marketCap":1507237},{"date":"2026-04-24","current":-0.044124,"twenty":-1.518322,"median":-0.89649,"eighty":-0.291771,"marketCap":1080186},{"date":"2026-05-01","current":-0.045417,"twenty":-1.507267,"median":-0.886242,"eighty":-0.278584,"marketCap":1111838},{"date":"2026-05-08","current":-0.03181,"twenty":-1.498068,"median":-0.879171,"eighty":-0.273751,"marketCap":778739},{"date":"2026-05-15","current":-0.040156,"twenty":-1.471705,"median":-0.838948,"eighty":-0.253079,"marketCap":983048},{"date":"2026-05-22","current":-0.079589,"twenty":-1.447326,"median":-0.833201,"eighty":-0.24422,"marketCap":936157},{"date":"2026-05-29","current":-0.078735,"twenty":-1.438334,"median":-0.830472,"eighty":-0.238761,"marketCap":926109},{"date":"2026-06-05","current":-0.086138,"twenty":-1.433681,"median":-0.820052,"eighty":-0.233015,"marketCap":1013193},{"date":"2026-06-12","current":-0.085426,"twenty":-1.429302,"median":-0.809929,"eighty":-0.222924,"marketCap":1004820},{"date":"2026-06-18","current":-0.090552,"twenty":-1.423276,"median":-0.772866,"eighty":-0.215898,"marketCap":1065109},{"date":"2026-06-26","current":-0.710801,"twenty":-1.405043,"median":-0.722364,"eighty":-0.218511,"marketCap":8360735},{"date":"2026-07-02","current":-0.645282,"twenty":-1.395821,"median":-0.717257,"eighty":-0.222397,"marketCap":7590071},{"date":"2026-07-10","current":-0.668406,"twenty":-1.391891,"median":-0.710801,"eighty":-0.222601,"marketCap":7862070},{"date":"2026-07-17","current":-0.691531,"twenty":-1.381965,"median":-0.692082,"eighty":-0.223409,"marketCap":8134069},{"date":"2026-07-24","current":-0.793939,"twenty":-1.368769,"median":-0.694243,"eighty":-0.230247,"marketCap":9338637},{"date":"2026-07-31","current":-0.739982,"twenty":-1.363165,"median":-0.710801,"eighty":-0.231574,"marketCap":8703972},{"date":"2026-08-07","current":-0.777422,"twenty":-1.345206,"median":-0.71717,"eighty":-0.23229,"marketCap":9144352},{"date":"2026-08-14","current":-0.782927,"twenty":-1.340648,"median":-0.720161,"eighty":-0.233644,"marketCap":9209113},{"date":"2026-08-21","current":-0.992645,"twenty":-1.256688,"median":-0.732274,"eighty":-0.235513,"marketCap":10967995}],"updateTime":1787585815278},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ASBP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659608211","title":"Aspire Biopharma Q2 FY26 Net Loss Narrows to $1.27 Million; Revenue Rises to $63,104","url":"https://stock-news.laohu8.com/highlight/detail?id=2659608211","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659608211?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:40","pubTimestamp":1786653647,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Q2 FY26 net loss narrows to $1.27 million; revenue rises to $63,104Aspire Biopharma posted Q2 net loss of USD 1.27 million, narrowing from USD 1.98 million a year earlier.Revenue was ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL10t9QH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659154911","title":"Aspire Biopharma to Present at Sidoti Micro-Cap Virtual Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2659154911","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659154911?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:15","pubTimestamp":1786623324,"startTime":"0","endTime":"0","summary":"Aspire Biopharma to present at Sidoti Micro-Cap Virtual Investor ConferenceAspire Biopharma will attend Sidoti’s Micro-Cap Virtual Investor Conference on Aug. 19-20, 2026.Management is scheduled to pr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL6tsPz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658936083","title":"Aspire Biopharma Completes $30 Million Acquisition of Dura Driver Control Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2658936083","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658936083?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:30","pubTimestamp":1786365032,"startTime":"0","endTime":"0","summary":"Aspire Biopharma completes $30 million acquisition of Dura Driver Control SystemsAspire Biopharma completed its acquisition of Dura Driver Control Systems, buying 100% of the shares for about USD 30 m","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL4dPt1D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655589788","title":"Aspire Biopharma Holdings Inc trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2655589788","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655589788?lang=en_us&edition=fundamental","pubTime":"2026-07-30 00:30","pubTimestamp":1785342642,"startTime":"0","endTime":"0","summary":"12:25 EDT Aspire Biopharma (ASBP) Holdings Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breakin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-holdings-inc-trading-resumes-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-holdings-inc-trading-resumes-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655892141","title":"NASDAQ Trade Halt Volatility Trading Pause at 12:20 Pm","url":"https://stock-news.laohu8.com/highlight/detail?id=2655892141","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655892141?lang=en_us&edition=fundamental","pubTime":"2026-07-30 00:20","pubTimestamp":1785342035,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 12:20 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nAQN2MC79R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653044246","title":"Aspire Biopharma Says ASPBW Warrants Now Carry Exercise Price of 13,800 Per Share After Reverse Splits","url":"https://stock-news.laohu8.com/highlight/detail?id=2653044246","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653044246?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:21","pubTimestamp":1784582475,"startTime":"0","endTime":"0","summary":"Aspire Biopharma says ASPBW warrants now carry exercise price of 13,800 per share after reverse splitsAspire Biopharma clarified terms of its public warrants (ASPBW) following two reverse stock splits","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDL8wDH6P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652215089","title":"Aspire Biopharma appoints Jarryd McNeil as sponsored athlete for BUZZ BOMB","url":"https://stock-news.laohu8.com/highlight/detail?id=2652215089","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652215089?lang=en_us&edition=fundamental","pubTime":"2026-07-20 20:45","pubTimestamp":1784551515,"startTime":"0","endTime":"0","summary":"Aspire Biopharma (ASBP) has named multi-time X Games medalist and freestyle motocross legend Jarryd McNeil as a sponsored athlete for its BUZZ BOMB...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-appoints-jarryd-mcneil-as-sponsored-athlete-for-buzz-bomb-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-appoints-jarryd-mcneil-as-sponsored-athlete-for-buzz-bomb-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SOCL","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646882350","title":"Aspire Biopharma Posts June 2026 Investor Presentation for On-demand Viewing","url":"https://stock-news.laohu8.com/highlight/detail?id=2646882350","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646882350?lang=en_us&edition=fundamental","pubTime":"2026-06-26 20:57","pubTimestamp":1782478626,"startTime":"0","endTime":"0","summary":"Aspire Biopharma posts June 2026 investor presentation for on-demand viewingAspire Biopharma published its June 2026 investor presentation for on-demand viewing at https://ir.aspirebiolabs.com/assets/","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL7N4lNb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645282818","title":"Aspire Unit Buzz Bomb Caffeine Launches BUZZ BOMB 50 Mg Caffeine Stick Packs on Amazon","url":"https://stock-news.laohu8.com/highlight/detail?id=2645282818","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645282818?lang=en_us&edition=fundamental","pubTime":"2026-06-24 20:30","pubTimestamp":1782304252,"startTime":"0","endTime":"0","summary":"Aspire unit Buzz Bomb Caffeine launches BUZZ BOMB 50 mg caffeine stick packs on AmazonAspire Biopharma’s wholly owned unit Buzz Bomb Caffeine Company launched BUZZ BOMB 50 mg caffeine stick packs on A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDL25KP4p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645837663","title":"Aspire Biopharma posts investor deck on sublingual drug-delivery platform, lead sublingual aspirin program","url":"https://stock-news.laohu8.com/highlight/detail?id=2645837663","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645837663?lang=en_us&edition=fundamental","pubTime":"2026-06-23 22:59","pubTimestamp":1782226749,"startTime":"0","endTime":"0","summary":"Aspire Biopharma outlined plans to acquire Dura Driver Control Systems for USD 30 million in cash, adding a business with 2025 revenue above USD 200 million.Dura reported 2025 net income above USD 17 million, adjusted EBITDA above USD 22 million, operations across 11 facilities, portfolio of 310+ patents.Lead prescription program OTASA 162 mg sublingual aspirin completed a July 2025 trial, showing therapeutic exposure at least five times faster than chewed tablets.FDA feedback supports a 505 filing in Q1 2027; IND planned for September; 32-subject crossover trial targeted for completion by end-2026.Consumer product BUZZ BOMB caffeine launched in Q3 2025; 50 mg sublingual powder format; distribution agreements cited with Amazon, TruLife, Interwest Brokerage.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL88kvTZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645390468","title":"Aspire Biopharma to present at Life Sciences Virtual Investor Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2645390468","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645390468?lang=en_us&edition=fundamental","pubTime":"2026-06-23 21:07","pubTimestamp":1782220054,"startTime":"0","endTime":"0","summary":"Aspire Biopharma will participate in the Life Sciences Virtual Investor Forum on June 24-25, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original content used to generate this news brief on June 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL8TlXnr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645070611","title":"Aspire Biopharma stockholders approve warrant share issuance proposal at special meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2645070611","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645070611?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:36","pubTimestamp":1782160581,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Holdings held a special shareholder meeting on June 16, 2026.Shareholders authorized issuance of common stock upon exercise of warrants, including shares above the 19.99% threshold, at an exercise price of $0.00001 per share.Investors also endorsed an adjustment to the number of common shares issuable upon exercise of the warrants under the warrant agreement with the company’s financial advisor.Shareholders approved voluntary adjustments to the warrants’ exercise price under the terms of the warrant.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL438gyY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644742408","title":"Aspire Biopharma to present at Life Sciences Investor Forum hosted by VirtualInvestorConferences.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2644742408","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644742408?lang=en_us&edition=fundamental","pubTime":"2026-06-17 22:58","pubTimestamp":1781708282,"startTime":"0","endTime":"0","summary":"Aspire Biopharma will present at the Life Sciences Investor Forum on June 25, 2026.The online presentation is scheduled for 2:00 p.m. ET.Management will be available for one-on-one meetings June 24-25, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL3smnYj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","SG9999014013.SGD","NDAQ","LU0314104364.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014039.USD","IE00BN0W2T93.GBP","LU2095319765.USD","LU2210150020.SGD","BK4007","IE00BN0W2W23.USD","ASBP","BK4112","IE00BN0W2V16.EUR","SG9999014005.SGD","BK4585","BK4588","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643183213","title":"Aspire Biopharma delays shareholder meeting to June 16 after lacking quorum","url":"https://stock-news.laohu8.com/highlight/detail?id=2643183213","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643183213?lang=en_us&edition=fundamental","pubTime":"2026-06-13 05:16","pubTimestamp":1781298985,"startTime":"0","endTime":"0","summary":"Aspire Biopharma adjourned its June 9, 2026 shareholder meeting due to lack of quorum.The meeting was rescheduled for June 16 at 10:00 a.m. EST.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL9XLtJF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643429783","title":"Aspire Biopharma Holdings Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2643429783","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643429783?lang=en_us&edition=fundamental","pubTime":"2026-06-13 02:10","pubTimestamp":1781287838,"startTime":"0","endTime":"0","summary":"14:07 EDT Aspire Biopharma (ASBP) Holdings Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-ti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-holdings-inc-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-holdings-inc-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643292761","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2643292761","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643292761?lang=en_us&edition=fundamental","pubTime":"2026-06-13 02:01","pubTimestamp":1781287309,"startTime":"0","endTime":"0","summary":"Adobe's  CFO departure and fiscal 2026 organic annual recurring revenue outlook have created more uncertainty for the company, outweighing its fiscal Q2 results, RBC Capital Markets said in a note emailed Friday.Shares of Adobe dropped 7%, with intraday trading volume rising to more than 19.0 million from the stock's daily average of about 5.71 million.Aspire Biopharma  agreed to acquire Dura Driver Control Systems, a manufacturer of automotive driver control systems, for $30 million in cash, according to a statement on Friday.Shares slumped 19%. Intraday trading volume stood at more than 10.0 million, versus a daily average of about 13.1 million.Price: 201.17, Change: -17.63, Percent Change: -8.06","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0342679015.USD","BK4007","SGXZ99366536.SGD","LU1712237335.SGD","LU0965509010.AUD","LU0289739343.SGD","SG9999001424.SGD","LU0069063385.USD","LU0170899867.USD","LU0158827948.USD","LU1674673691.USD","LU0198837287.USD","LU1720051017.SGD","BK4534","LU2458330243.SGD","LU2210149790.SGD","LU2089283258.USD","IE0009356076.USD","LU1691799644.USD","LU0792757196.USD","LU1633808545.USD","LU0868494617.USD","LU2125154935.USD","LU0289961442.SGD","LU0348723411.USD","LU0157215616.USD","LU1366333091.USD","BK4588","LU0557290698.USD","LU1674673428.USD","LU2357305700.SGD","LU2360032135.SGD","LU0672654240.SGD","ADBE","LU0719512351.SGD","LU0314104364.USD","LU2095319765.USD","LU1815333072.USD","LU0472753341.HKD","BK4585","LU2236285917.USD","LU0234570918.USD","LU2237438978.USD","LU1084165304.USD","LU1823568750.SGD","IE00B5TLWC47.USD","IE00BYQQ9H92.USD","LU0965509101.SGD","LU0861579265.USD","LU0868494708.USD","LU0057025933.USD","BK4543","BK4023","LU0006306889.USD","ADBG","LU0109391861.USD","IE00BQXX3D17.EUR","LU0345774391.USD","LU0708995401.HKD","LU0320765059.SGD","BK4527","LU1235294995.USD","LU1778281490.HKD","BK4581","ASBP","BK4592","LU0061474960.USD","LU0106261372.USD","LU0965509283.SGD","SGXZ51526630.SGD","LU2023251221.USD","LU0889565833.HKD","LU0082616367.USD","LU1046421795.USD","BK4566","LU1803068979.SGD","LU1267930813.SGD","LU0957791311.USD","SG9999000418.SGD","LU0345774631.USD","LU0081259029.USD","LU1623119135.USD","LU2317271919.USD","LU1119994496.HKD","IE00B19Z9505.USD","SGXZ81514606.USD","LU2458330169.SGD","BK4554","LU0889566641.SGD","IE00BQXX3F31.USD","LU0109392836.USD","LU0234572021.USD","LU2125154778.USD","LU1261432733.SGD","BK4533","LU0942090050.USD","LU2210150020.SGD","LU1720051108.HKD","IE00BFXG0V08.USD","IE00BQXX3C00.GBP","LU1548497426.USD","LU0511384066.AUD","BK4567","LU2089284900.SGD","LU1267930730.SGD","BK4528"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642877299","title":"Press Release: Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2642877299","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642877299?lang=en_us&edition=fundamental","pubTime":"2026-06-12 22:33","pubTimestamp":1781274780,"startTime":"0","endTime":"0","summary":"-- Adds an established global brand with scale in large and growing markets. driven by trends in vehicle and mobility control systems. -- Acquisition significantly accelerates Aspire's revenue, earnings growth. -- Opportunity to drive significant shareholder value creation and enhance. -- Company does not anticipate procuring new equity financing to consummate. ESTERO, FL / ACCESS Newswire / June 12, 2026 / Aspire Biopharma Holdings,signing of a definitive Share Purchase Agreement  for the. acquisition of 100% of Dura Driver Control Systems , a premier. designer and manufacturer of automotive driver control systems with. The proposed acquisition represents a transformative milestone for. Aspire, positioning the Company to rapidly evolve into a diversified,\"We are thrilled to welcome the DCS team into Aspire and to build a. said Kraig Higginson, Interim CEO and Chairperson of the Aspire. Biopharma Board. \"Our acquisition of DCS, an established global. Pursuant to the terms of the SPA, A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642296701","title":"Aspire Biopharma - Enters Purchase Agreement With Firefish Topco on June 10, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2642296701","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642296701?lang=en_us&edition=fundamental","pubTime":"2026-06-12 22:28","pubTimestamp":1781274497,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nFWN42K080:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642296065","title":"Aspire Biopharma - to Pay $30 Mln Plus $800,000 Deferred Revenue as Purchase Price - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2642296065","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642296065?lang=en_us&edition=fundamental","pubTime":"2026-06-12 22:28","pubTimestamp":1781274497,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nFWN42K080:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642129826","title":"Aspire Biopharma signs agreement to buy Dura Driver Control Systems for $30 million cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2642129826","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642129826?lang=en_us&edition=fundamental","pubTime":"2026-06-12 20:30","pubTimestamp":1781267457,"startTime":"0","endTime":"0","summary":"Aspire Biopharma signed a definitive share purchase agreement to buy Dura Driver Control Systems for USD 30 million cash.Target posted FY2025 unaudited revenue above USD 200 million, net income above USD 17 million, adjusted EBITDA above USD 22 million.Deal expected to close in Q3 2026, subject to customary closing conditions.Dura Driver Control Systems will become a wholly owned subsidiary; CEO Hans Vorstenbosch is set to remain in charge.Buyer indicated it does not anticipate raising new equity to complete the acquisition.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL1gNmQy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":53,"code":"91000000","status":"200"}]}}